Oregon Drug and Alcohol Inpatient Treatment Licensing

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

Apply now: OHA Residential Treatment Facilities page (application forms and SUD contacts) | Questions: the regional SUD compliance specialist emails listed on that page (OHA lists no phone numbers for them)

An Oregon residential addiction license is unusually specific about what it covers. Since April 1, 2024, every adult residential substance use disorder license issued by the Oregon Health Authority (OHA), Behavioral Health Division, Licensing and Certification has had to name at least one ASAM level of care the program is approved for, and the license also has to say whether the program is an IMD or a non-IMD residential setting (OAR 309-018-0108). So the document on your wall tells a reviewer, in writing, that you run Level 3.5, or 3.1 and 3.7, and nothing else. Getting there starts with a meeting rather than a form. OAR 415-012-0030 requires a first-time applicant to schedule a meeting with the Division “for the purpose of receiving needed technical assistance” before the license moves forward.

Which Rules Apply to a Residential SUD Program

Oregon splits the work across two rule divisions. The license itself comes from OAR 415-012, which says a residential treatment facility or a detoxification center “shall be licensed by the Division” and bars an unlicensed one from admitting people who need residential or detoxification care (415-012-0020(3)). Day-to-day service delivery, staffing and the ASAM level standards sit in OAR 309-018. Withdrawal management has its own service rules in OAR 415-050, but it is licensed through the same 415-012 process, at ASAM 3.2-WM (clinically managed) or 3.7-WM (medically monitored) under 415-050-0110.

The residential levels Oregon licenses are 3.1, 3.3, 3.5 and 3.7, with the standards for each in OAR 309-018-0181 to 309-018-0184. A program may also carry an Enhanced designation for co-occurring or biomedical services. Under state statute a facility serving six or more people with alcohol or drug dependence is a residential treatment facility, and one serving five or fewer is a residential treatment home (ORS 443.400). On its residential page, OHA puts the SUD residential size at “up to 16 individuals, including detoxification programs.”

OHA has also fixed a date for the ASAM Criteria, Fourth Edition. A July 30, 2025 memo moved it, and OHA’s ASAM page now says current levels are extended through June 30, 2027, with the Fourth Edition effective July 1, 2027. A program opening in 2026 or early 2027 should write its policies to the current levels and budget time to rewrite them.

CARF’s Level of Care Certification Is a Second, Separate Proof

Oregon’s license already prints the level, which makes the CARF option less about filling a gap and more about outside validation. CARF’s ASAM Level of Care Certification is the only certification ASAM has approved, and both CARF and ASAM limit it, for now, to adult residential care at Levels 3.1, 3.5 and 3.7. It is a separate route to a recognized Level 3.7 that OHA does not issue or require, at least on the OHA pages and memo we read. Two gaps matter for an Oregon operator. A Level 3.3 program has nothing to certify, since CARF’s levels stop at 3.1, 3.5 and 3.7, and a 3.7-WM detox unit sits outside it too, because neither CARF nor ASAM says the certification reaches withdrawal management. A certified program can be found through CARF’s provider search with the ASAM Level of Care filter. How much weight an Oregon referral source gives it is our guess, not something OHA has addressed.

No Certificate of Need, and No Deemed Status Either

Oregon’s Certificate of Need statute, ORS 442.315, reaches new hospitals and new skilled nursing or intermediate care services. The definition of “health care facility” in ORS 442.015(12)(b) leaves out residential facilities licensed by OHA under ORS 443.415 and facilities set up under ORS 430.335 for substance use treatment, so a freestanding residential SUD program does not need one. Among behavioral health settings, the ones that do need a certificate are a new freestanding psychiatric hospital and a psychiatric unit that counts as a “new hospital,” and OHA adopted a need method for those effective April 17, 2026 (PH 19-2026).

Accreditation will not shorten the OHA review. Nothing in OAR 415-012, 309-018-0108 or OHA’s licensing pages, as we read them, gives CARF, Joint Commission or COA accreditation deemed status. That gap is a little surprising, because Oregon studied the idea. A 2024 Legislative Fiscal Office packet includes a December 12, 2023 OHA letter saying “OHA agrees with using a ‘recognition’ status” for accredited SUD providers. We have not found a rule that followed through, so for now accreditation earns its keep with payers and referral partners, and the two-year OHA license review happens regardless.

MOUD Rules Inside an Oregon Residential Program

Two Oregon rules go further than a general access policy. OAR 309-018-0135(1)(c) says a residential provider “may not deny entry to individuals based on the individual’s decision to continue their currently prescribed medication” for opioid dependence. And OAR 309-018-0110(4)(e) requires written policies that “Prohibit titration of medications prescribed for the treatment of opioid dependence” as a condition of getting or staying in treatment. Put plainly, a person admitted on buprenorphine or methadone stays on it, and a bed can’t be conditioned on tapering off.

Methadone for opioid use disorder is dispensed through opioid treatment programs, which Oregon regulates under their own standards in OAR 415-020, so in our view a house admitting people on methadone needs a working agreement with an OTP that covers dosing and transport. Buprenorphine is easier to handle in-house. DEA’s January 12, 2023 letter says “all prescriptions for buprenorphine only require a standard DEA registration number.” For naltrexone, SAMHSA says it “can be prescribed and administered by any practitioner licensed to prescribe medications.” Medical protocols for all of this have to be approved by the program’s medical director (OAR 309-018-0185).

Adding Ketamine to an Oregon Residential License

Ketamine appears nowhere in OAR 415-012 or 309-018, and OHA has published no guidance on it that we could locate. This section applies the licensing rules, the nursing board’s sedation guidance and the ownership statutes cited below as we interpret them, and your OHA compliance specialist should hear the plan before any resident is dosed.

Because Oregon organizes the residential license around ASAM levels rather than drugs, there is no ketamine designation to apply for when a resident’s depression or PTSD hasn’t budged. A notice duty can still apply. OAR 415-012-0040 requires 30 days’ notice before a program changes its treatment philosophy, and a medical protocol for a dissociative drug is the kind of change we would report rather than argue about. The protocol itself needs medical director approval under OAR 309-018-0185.

Level of care matters a lot here. At Level 3.7, OAR 309-018-0184 puts staff on site around the clock, a licensed medical practitioner on site daily and available 24 hours a day, and medical treatment staff trained to recognize the signs of acute psychiatric conditions. A Level 3.1 house has nothing like that, and in our view it is the wrong setting to give a dose and watch someone through the next two hours.

What Oregon’s Nursing Board Has and Hasn’t Said

The Oregon State Board of Nursing has no statement on ketamine for depression. Its closest document is a 2024 guide, Nursing Scope of Practice for the Use of Sedating and Anesthetic Agents, which says RNs and APRNs “may administer Ketamine under a LIP’s direction in non-intubated patients” in an acute care context, and, answering a question about an LPN asked to give an IV ketamine bolus for pain, says that “is not within the LPN’s scope of practice since Ketamine is classified as an anesthetic.” For sedation in clinic or office settings it asks for a licensed independent practitioner “immediately available,” written protocols and continuous monitoring. We would staff a residential ketamine dose to that standard and keep LPNs away from IV administration.

Registrations and Monitoring

Ketamine is federally Schedule III (21 CFR 1308.13(c)(7)), and 21 CFR 1301.12 ties each DEA registration to a place of practice, so the residence needs to be covered. ORS 475.125 does call for an annual State Board of Pharmacy registration from anyone who dispenses controlled substances, but subsection (3)(d) excludes practitioners licensed in Oregon with authority to dispense, so we read it as adding nothing for the prescriber. Prescribers must register with the Oregon PDMP (ORS 431A.877), but ORS 431A.860 bars OHA from requiring reports of drugs “administered directly to a patient,” so an in-house dose doesn’t show up there while a filled take-home prescription does. Esketamine, sold as Spravato, can only be given in a setting enrolled in its REMS program, and the FDA label and medication guide have the patient watched for no less than two hours after each dose. None of this touches the MOUD rules above, which protect opioid use disorder medications, and ketamine is not one of them.

Who Owns the Clinic After Discharge

In our experience few ketamine series finish before discharge. Whatever doses remain tend to move to an office-based clinic once the resident leaves, and Oregon rewrote the ownership rules for that kind of clinic in 2025. A professional corporation practicing medicine has to have Oregon-licensed physicians holding a majority of each voting share class and making up most of the board (ORS 58.500, formerly 58.375). ORS 58.503 lets physicians, physician associates and nurse practitioners form one corporation together, as long as licensees hold the majority.

The usual workaround in other states, an investor-owned management services organization running the business side, now has limits. SB 951 (2025), enacted as Oregon Laws 2025 chapter 295 and codified at ORS 676.555, says an MSO, and the people who own, direct or work for it, may not hold or control most of the shares of a medical entity it has a management contract with. It also forbids de facto MSO control over matters such as clinician hiring, diagnostic coding, clinical standards and pricing. Those limits reach MSOs and medical entities organized after the law’s effective date starting January 1, 2026, and pre-existing ones starting January 1, 2029. The law exempts an entity that provides behavioral health care “that the Oregon Health Authority has certified,” but in our reading a ketamine clinic without OHA certification gets no benefit from that. The licensing side of that clinic is in the ketamine section of Oregon Drug and Alcohol Outpatient Treatment Licensing.

If the program sends discharged residents to a clinic it has any financial tie to, two anti-kickback laws come into play. ORS 676.553 bars a substance use, problem gambling or mental health provider from handing over or taking “a fee, commission, bonus, rebate” or other compensation in exchange for referring an Oregon resident. At the federal level, 18 U.S.C. § 220 (usually called EKRA) covers clinical treatment facilities licensed or certified by a state, with penalties of up to $200,000 in fines, 10 years in prison, or both, for each occurrence. Have counsel review the arrangement before the first referral.

Staffing a Residential Program in Oregon

Under OAR 309-018-0125(8), a treatment staffer without certification gets 30 days from hire to register with the credentialing body OHA recognizes and two years from first hire to become certified. In Oregon that body is the Mental Health and Addiction Certification Board of Oregon (MHACBO). Past the CADC-R registration, its CADC I takes 150 education hours plus 1,000 supervised hours, the CADC II adds a bachelor’s degree or 90 college credits with 300 education hours and 4,000 supervised hours, and the CADC III requires a master’s degree and 6,000 supervised hours. Oregon pays these counselors well. The Oregon median for substance abuse, behavioral disorder, and mental health counselors is $74,590 in BLS’s OEWS figures for May 2025, the middle half of earners fall between $60,130 and $86,800, and the national median is $59,350. By our own budgeting math, a 16-bed house with a clinical director, four counselors and awake staff around the clock runs past $550,000 a year before nursing or a medical director. You probably won’t need to fund that whole figure in year one, since Oregon’s two-year registration window lets a program bring its own counselors up through the tiers. Many Oregon programs we work with hire CADC-R counselors and CADC I holders who need supervised hours for the next tier, place them under a qualified clinical supervisor (OAR 309-018-0125(4) asks for 4,000 supervised hours and 300 contact hours on the certified route), and pay them less while they earn those hours, which tends to bring clinical payroll 40 to 60 percent under what a fully credentialed team would cost. On the medical side, one RN supervising several LPNs usually costs less than an all-RN schedule, as long as LPNs stay out of anything the nursing board reserves for RNs. Once you know your bed count and which levels OHA will print on the license, we can lay out the actual shift schedule.

How to Submit Your Oregon Residential SUD Application

OHA does not post a single online application for SUD residential licensing. Under OAR 415-012-0030 the Division sends the application packet, each location needs its own application, and a first-time applicant schedules the technical assistance meeting before anything else. Start by emailing the SUD compliance specialist for your region, listed on OHA’s Residential Treatment Facilities page. The table there names contacts for the Portland tri-county area, for statewide work, for Eastern and Central Oregon and for Southern Oregon, with email addresses only.

The ASAM levels go on separate forms from OHA’s ASAM page: a Main Level of Care Application plus a Residential addendum, and a Withdrawal Management application for 3.2-WM or 3.7-WM. ORS 443.415(2) puts the fee at $60 when the program is a residential treatment facility (six or more residents) and $30 when it is a residential treatment home (five or fewer). OAR 415-012 itself states no fee, so applying the statute to SUD programs is our reading. After the onsite review, OHA issues its report within 30 days, and a plan of correction is due within 30 days of the final report, with extensions of up to 90 days possible (OAR 415-012-0055). The license runs up to two years (415-012-0040), and it can’t be moved to another owner or another address.

Common Snags in Oregon Residential Files

The slowest files we see treat the ASAM forms as paperwork to finish last. The level drives staffing, physical plant and medical coverage, and an applicant who asks for 3.7 with a 3.1 staffing plan gets sent back. The other recurring problem is policy manuals copied from another state that say nothing about the MOUD admission rule or the titration ban, both of which a reviewer will look for. Our own planning range for a new residential program, from that first meeting through a license, is roughly 8 to 12 months, much of it build-out, zoning and fire inspection rather than OHA review.

Frequently Asked Questions

Getting ready for that first technical assistance meeting with OHA? Let’s compare notes before you walk in.

Sources

• OHA Licensing and Certification: Residential and Outpatient Behavioral Health Programs (checked October 11, 2026)
• OHA Licensing and Certification: Residential Treatment Facilities (forms, SUD contacts, two-year licensing) (checked October 11, 2026)
• OHA: ASAM Criteria page and level of care applications and July 30, 2025 ASAM update memo (PDF) (checked October 11, 2026)
• OAR 309-018-0108, via Cornell LII (verbatim mirror): Residential licensing, ASAM levels and IMD status (checked October 11, 2026)
• OAR 415-012-0020, 415-012-0030, 415-012-0040 and 415-012-0055, via Cornell LII: licensure required, application and technical assistance meeting, license term and notices, review report and plan of correction (checked October 11, 2026)
• OAR 415-050-0110, via Cornell LII: Withdrawal management licensing and levels (checked October 11, 2026)
• OAR 309-018-0110, 309-018-0125, 309-018-0135, 309-018-0184 and 309-018-0185, via Cornell LII: policies, staff qualifications, entry and MOUD, ASAM 3.7 staffing, medical protocols, plus the Division 18 index (ASAM Levels 3.1 to 3.7 at 309-018-0181 to 0184) and OAR 415-020, outpatient opioid treatment program standards (checked October 11, 2026)
• ORS 443.400 and 443.415, via Justia (verbatim mirror): facility definitions and license fees (checked October 11, 2026)
• ORS 442.015, via Justia: health care facility definition, and OHA: Certificate of Need program and PH 19-2026, psychiatric hospital need (PDF) (checked October 11, 2026)
• Oregon Legislative Fiscal Office: OHA Substance Use Disorder Provider Accreditation packet, January 2024 (checked October 11, 2026)
• CARF: ASAM Level of Care Certification and Find a Provider, and ASAM: Level of Care Certification (checked October 11, 2026)
• DEA Diversion Control Division: Dear Registrant letter, January 12, 2023 (PDF) (checked October 11, 2026)
• SAMHSA: Naltrexone (checked October 11, 2026)
• Oregon State Board of Nursing: Nursing Scope of Practice for the Use of Sedating and Anesthetic Agents (PDF) (checked October 11, 2026)
• eCFR, 21 CFR 1308.13(c)(7): ketamine in Schedule III, and 21 CFR 1301.12 via Cornell LII: separate registration for each place of practice (checked October 11, 2026)
• U.S. FDA: Spravato prescribing information and Medication Guide (PDF) (checked October 11, 2026)
• ORS 475.125, 431A.860 and 431A.877, via Justia: controlled substance registration, PDMP reporting, PDMP registration (checked October 11, 2026)
• ORS 58.500 and 58.503, via Justia: medical professional corporations and joint corporations with PAs and NPs (checked October 11, 2026)
• Oregon Legislature, SB 951 (2025): measure overview and enrolled text, plus ORS 676.555 via Justia: management services organizations (checked October 11, 2026)
• ORS 676.553, via Justia: referral fees for substance abuse and mental health services (checked October 11, 2026)
• 18 U.S.C. § 220, via Cornell LII: Illegal remunerations for referrals (checked October 11, 2026)
• MHACBO: CADC I, CADC II, CADC III (checked October 11, 2026)
• BLS OEWS, May 2025, SOC 21-1018: OEWS tables (checked October 11, 2026)